The FY2024 report certifies 172,111.30 appropriated or encumbered but not yet spent at 06/30/2024 (p1, Q7). It is the same figure the report gives as the Class I's program's expended amount (p3). None of the three opioid accounts shows an open purchase order at 06/30/2024. The first opioid encumbrances are purchase order 24-03656 on 08/14/2024, purchase order 24-03379 on 08/22/2024 and purchase order 24-04670 on 10/11/2024.
